Acadia Pharmaceuticals Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2010 | 51.0% | 51.0% | 39.4% |
| FY2011 | -97.4% | -97.4% | -70.9% |
| FY2012 | -24.5% | -24.5% | -19.2% |
| FY2013 | -20.8% | -20.8% | -20.1% |
| FY2014 | -29.9% | -29.9% | -28.4% |
| FY2015 | -82.3% | -82.3% | -74.1% |
| FY2016 | -52.4% | -52.4% | -48.4% |
| FY2017 | -86.3% | -86.3% | -75.3% |
| FY2018 | -51.2% | -51.2% | -45.4% |
| FY2019 | -33.7% | -33.7% | -30.0% |
| FY2020 | -44.9% | -44.9% | -36.0% |
| FY2021 | -31.0% | -31.0% | -24.0% |
| FY2022 | -53.9% | -53.9% | -36.7% |
| FY2023 | -14.2% | -14.2% | -8.2% |
| FY2024 | 30.9% | 30.9% | 19.1% |
| FY2025 | 31.9% | 31.9% | 25.0% |